Abstract
Perioperative tumor growth acceleration is associated with inflammatory pathway activation. Non-steroidal anti-inflammatory drugs, particularly ketorolac, are a promising way to improve patient outcome.
| Translated title of the contribution | A single intraoperative dose of original ketorolac to prevent cancer recurrence: Is that too simple? |
|---|---|
| Original language | French |
| Pages (from-to) | 391-395 |
| Number of pages | 5 |
| Journal | Louvain Medical |
| Volume | 133 |
| Issue number | 6 |
| Publication status | Published - Jun 2014 |
Keywords
- Ketorolac
- postoperative cancer recurrence
- Inflammation
